首页> 外文期刊>Neuro-Oncology >Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases
【24h】

Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases

机译:少突胶质细胞瘤的预后变量:单机构研究95例

获取原文
获取原文并翻译 | 示例
           

摘要

We analyzed the relationships among clinical variables, histology, lp/19q status, and outcome in 95 patients with oligodendroglial tumors.The study enrolled adult patients who underwent first-time surgery for a supratentorial oligodendroglial tumor at Oslo University Hospital, Rikshospitalet. Tumors were: 27 oligodendrogliomas, WHO grade Ⅱ; 32 oli-goastrocytomas, WHO grade Ⅱ; 16 anaplastic oligodendrogliomas, WHO grade Ⅲ; 14 anaplastic oligoastrocytomas, WHO grade Ⅲ; and 6 glioblastomas with a major oligodendroglial component, WHO grade IV. The clinical files were reviewed. Three neuropathologists evaluated the histological slides independently. Loss-of-heterozygosity analysis for 1p and 19q was performed by PCR.Favorable prognostic factors from univariate analyses included seizures as presenting symptom, female sex, location in the frontal lobe, low WHO grade, classic histology, absence of gemistocytic cells, and combined lp/19q loss. Solitary 19q loss was a negative prognostic marker. lp/19q status was of prognostic significance in both tumors with classic and nonclassic oligodendroglial histology. In the multivariate analysis, WHO grade II (P<.001), frontal tumor location (P = .002), and combined lp/19q loss (P<.001) remained favorable prognostic variables.Our results suggest that tumor location, WHO grade, and lp/19q status are important independent variables associated with survival in oligodendroglial tumors. The study suggests that solitary 19q loss is a negative prognostic variable and that lp/19q loss is associated with prolonged survival also in oligodendroglial tumors without classic histology.
机译:我们分析了95例少突神经胶质瘤患者的临床变量,组织学,lp / 19q状况和结局之间的关系。该研究招募了在Rikshospitalet的奥斯陆大学医院首次接受了幕上少突神经胶质瘤手术的成年患者。肿瘤为:WHOⅡ级27例少突胶质细胞瘤。世卫组织Ⅱ级32例少代星形细胞瘤;世界卫生组织Ⅲ级16例间变性少突胶质细胞瘤。世界卫生组织Ⅲ级14例间变性少星形细胞瘤;以及6个具有主要少突神经胶质成分的胶质母细胞瘤,世卫组织IV级。临床文件进行了审查。三位神经病理学家独立评估了组织切片。通过PCR对1p和19q进行杂合缺失分析,单因素分析的有利预后因素包括癫痫发作,症状,女性,额叶位置,WHO分级低,经典组织学,双核细胞缺乏和综合lp / 19q损失。单独的19q丢失是阴性的预后指标。 lp / 19q状态在具有经典和非经典性少突胶质细胞学的肿瘤中均具有预后意义。在多变量分析中,WHO II级(P <.001),额部肿瘤位置(P = .002)和lp / 19q合并丢失(P <.001)仍是有利的预后变量。等级和lp / 19q状态是与少突胶质瘤生存相关的重要独立变量。该研究表明,在没有经典组织学的情况下,少突胶质细胞瘤中单独的19q丢失是负的预后变量,而lp / 19q丢失也与延长的生存期有关。

著录项

  • 来源
    《Neuro-Oncology》 |2011年第11期|p.1225-1233|共9页
  • 作者单位

    Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway;

    Department of Neurosurgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway;

    Cancer Registry of Norway, Oslo, Norway;

    Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway;

    The Gade Institute, Department of Pathology, Haukeland University Hospital, Bergen, Norway;

    Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway;

    Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway;

    Department of Neurosurgery, Oslo University Hospital, Ullevil Hospital, Oslo, Norway;

    Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    oligodendroglioma; lp; 19q; prognostic;

    机译:少突胶质细胞瘤lp;19q;预后的;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号